Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gynecologic 2

Conditions

Ovarian Neoplasms 799Uterine Cervical Neoplasms 537Endometrial Neoplasms 459Breast Neoplasms 221Fallopian Tube Neoplasms 198Colorectal Neoplasms 179Carcinoma, Non-Small-Cell Lung 163Neoplasms 137Stomach Neoplasms 127Pancreatic Neoplasms 118Prostatic Neoplasms 107Neoplasm Metastasis 107Melanoma 107Lung Neoplasms 103Carcinoma, Ovarian Epithelial 92Triple Negative Breast Neoplasms 91Squamous Cell Carcinoma of Head and Neck 82Esophageal Neoplasms 77Head and Neck Neoplasms 75Carcinoma, Renal Cell 75Urinary Bladder Neoplasms 74Uterine Neoplasms 66Vulvar Neoplasms 64Colonic Neoplasms 59Peritoneal Neoplasms 58Carcinoma, Hepatocellular 58Uterine Cervical Dysplasia 57Sarcoma 52Carcinoma, Transitional Cell 48Papillomavirus Infections 47

Interventions

relugolix 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Myofibroma × Gynecologic × 1 year × Clear all
NCT07250178 2026-01-07

ONSD as an ICP Marker in vNOTES and TLH

Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital

Phase NA Completed
66 enrolled
Gynecologic

Metrorrhagia, Endometrial Neoplasms, Myofibroma

NCT06953076 2025-08-17

MySaturn

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Recruiting
111 enrolled
Gynecologic

Leiomyoma, Myoma, Uterine Hemorrhage, Uterine Neoplasms, Myofibroma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡